Veterinary uses of recombinant human granulocyte colony-stimulating factor. Part I. Oncology

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 20, Issue 6, 1998, Pages 728-734

  Henry, Carolyn J ^a,c   Buss, Michael S ^a,c   Lothrop Jr , Clinton D ^b,d  

^a UNIVERSITY OF MISSOURI   (United States)

^b AUBURN UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d AMER COLL OF VET INT MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANINE PARVOVIRUS; CANIS FAMILIARIS; FELIS CATUS; PARVOVIRUS;

EID: 0042241734     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Gualtieri RJ, Liang C-M, Shadduck RK, et al: Identification of the hematopoietic growth factors elaborated by bone marrow stromal cells using antibody neutralization analysis. Exp Hematol 15:883-889, 1987.
2. Abbas AK, Lichtman AH, Pober JS: Cytokines, in Abbas AK, Lichtman AH, Pober JS (eds): Cellular and Molecular Immunology, ed 2. Philadelphia, WB Saunders Co, 1994, pp 240-260.
3. Zsebo KM, Yuschenkoff VN, Schiffer S, et al: Vascular endothelial cells and granulopoiesis: Interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 71:99-103, 1988.
4. Rafii S, Shapiro F, Pettengell R, et al: Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86:3353-3363, 1995.
5. Metcalf D, Nicola NA: Synthesis by mouse peritoneal macrophages of G-CSF, the differentiation inducer for myeloid leukemia cells: Stimulation by endotoxin, M-CSF and multi-CSF. Leuk Res 9:35-50, 1985.
6. Korpelainen EI, Gamble JR, Smith WB, et al: Interferon-gamma upregulates interleukin-3 (IL-3) receptor expression in human endothelial cells and synergizes with IL-3 in stimulating major histocompatibility complex class II expression and cytokine production. Blood 86:176-182, 1995.
7. Tsuji T, Sugimoto K, Yanai T, et al: Induction of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) expression in bone marrow and fractionated marrow cell populations by interleukin 3 (IL-3): IL-3-mediated positive feedback mechanisms of granulopoiesis. Growth Fact 11:71-79, 1994.
8. Griffin JD: Hematopoietic growth factors, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer Principles and Practice of Oncology, ed 5. Philadelphia, Lippincott-Raven Publishers, 1997, pp 2639-2657.
9. Foxwell BMJ, Barrett K, Feldman M: Cytokine receptors: Structure and signal transduction. Clin Exp Immunol 90: 161-169, 1992.
10. Shimoda K, Okamura S, Harada N, et al: Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 91:1310-1313, 1993.
11. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28-35, 1992.
12. Duhrsen U, Villeval JL, Boyd JL, et al: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081, 1988.
13. Lord BI, Bronchud MK, Owens S, et al: The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci USA 86:9499-9503, 1989.
14. Metcalf D, Morstyn G: Colony-stimulating factors: General biology, in DeVita VT, Hellman S, Rosenberg SA (eds): Biologic Therapy of Cancer. Philadelphia, JB Lippincott Co, 1991, pp 417-444.
15. Metcalf D: Control of granulocytes and macrophages: Molecular, cellular, and clinical aspects. Science 254:529-533, 1991.
16. Zsebo KM, Cohen AM, Murdock DC, et al: Recombinant human granulocyte colony stimulating factor: Molecular and biological characterization. Immunobiology 172:175-184, 1986.
17. Platzer E, Oez S, Welte K, et al: Human pluripotent hemopoietic colony stimulating factor: Activities on human and mutine cells. Immunobiology 172:185-193, 1986.
18. Sullivan R, Griffin JD, Simmons ER, et al: Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. J Immunol 139:3422-3430, 1987.
19. Lindemann A, Herrmann F, Oster W, et al: Hematologic effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081, 1988.
20. Miles SA, Mitsuyasu RT, Lee K, et al: Recombinant granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe human immunodeficiency virus infection. Blood 75(11):2137-2142, 1990.
21. Miles SA, Mitsuyasu RT, Moreno J, et al: Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood 77:2109-2117, 1991.
22. Lothrop CD, Warren DJ, Souza LM, et al: Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 72:1324-1328, 1988.
23. Lovejoy B, Cascio D, Eisenberg D: Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF). J Molec Biol 234:640-653, 1993.
24. Hammond WP, Csiba E, Canin A, et al: Chronic neutropenia: A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest 87:704-710, 1991.
25. Mishu L, Callahan G, Allebban Z, et al: Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs. JAVMA 200:1957-1964, 1992.
26. Obradovich JE, Ogilvie GK, Powers BE, et al: Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. J Vet Intern Med 5:75-79, 1991.
27. Goodman SA, McPherson J, Rossmeisel JA, et al: Recombinant human granulocyte colony stimulating factor decreases myelosuppression in normal dogs following repeated cycles of mitoxantrone and cyclophosphamide chemotherapy without development of neutralizing antibodies. J Vet Intern Med, submitted for publication.
28. Henry CJ, Lothrop CD, Goodman S: Dogs receiving mitoxantrone and cyclophosphamide combination therapy do not produce clinically significant antibody titers to rhG-CSF. Proc 13th Annu ACVIM Vet Forum:1020, 1995.
29. Fulton R, Gasper PW, Ogilvie GK, et al: Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats. Exp Hematol 19:759-767, 1991.
30. Obradovich JE, Ogilvie GK, Stadler-Morris S, et al: Effect of recombinant canine granulocyte colony-stimulating factor on peripheral blood neutrophil counts in normal cats. J Vet Intern Med 7:65-67, 1993.
31. Ogilvie GK, Obradovich JE, Cooper MF, et al: Use of recombinant canine granulocyte colony-stimulating factor to decrease myelosuppression associated with the administration of mitoxantrone in the dog. J Vet Intern Med 6:44-47, 1992.
32. Bunn P, Crowley J, Kelly K, et al: Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol 13:1632-1641, 1995.
33. Momin F, Kraut M, Lattin P, et al: Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non-small cell lung cancer (NSCLC). Proc Annu Meet Am Soc Clin Oncol: 11, 1992.
34. Physicians' Desk Reference, ed 51. Montvale, NJ, Medical Economics, 1997, pp 495-501.
35. Weiss AJ, Lackman RD: Infusional chemotherapy combined with recombinant human granulocyte colony stimulating factor: Advantages and limitations. Am J Clin Oncol 20(1): 63-68, 1997.
36. Jeglum KA: Clinical applications of biological response modifiers. Proc 12th Annu ACVIM Vet Forum:287-290, 1994.
37. Bravo L, Legendre AM, Hahn KA, et al: Serum granulocyte colony-stimulating factor (G-CSF) and interleukin-1 (IL-1) concentrations after chemotherapy-induced neutropenia in normal and tumor-bearing dogs. Exp Hematol 24:11-17, 1996.
38. Gabrilove JL, Jakubowski A, Scher H, et al: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-1422, 1988.
39. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:1773-1778, 1991.
40. American Society of Clinical Oncology: Recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines. J Clin Oncol 12:2471-2508, 1994.
41. Morstyn G, Campbell L, Lieschke GJ, et al: Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1:667-672, 1988.
42. Bronchud MH, Potter MR, Morgenstern G, et al: In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Canc 58:64-69, 1988.
43. Gabrilove JL, Jakubowski A, Fain K, et al: Phase I study of granulocyte colony stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 82: 1454-1461, 1988.